Tekla Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Tekla Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.12M	Hold	24,569	–	–	0.12%	99
2023 Q1	$3.17M	Hold	24,569	–	–	0.12%	95
2022 Q4	$3.23M	Hold	24,569	–	–	0.12%	95
2022 Q3	$2.87M	Buy	+24,569	New	+$3.05M	0.12%	99
2020 Q1	–	Sell	-38,834	Closed	-$4.68M	–	219
2019 Q4	$4.68M	Buy	38,834 +19,920	+105%	+$2.22M	0.18%	108
2019 Q3	$1.88M	Buy	+18,914	New	+$1.98M	0.08%	138
2017 Q3	–	Sell	-227,910	Closed	-$23.6M	–	156
2017 Q2	$23.6M	Sell	227,910 -6,000	-3%	-$591K	0.87%	29
2017 Q1	$22.9M	Buy	233,910 +60,900	+35%	+$5.83M	0.89%	27
2016 Q4	$15.3M	Hold	173,010	–	–	0.65%	33
2016 Q3	$16.7M	Hold	173,010	–	–	0.64%	36
2016 Q2	$14.8M	Hold	173,010	–	–	0.61%	38
2016 Q1	$15M	Hold	173,010	–	–	0.64%	36
2015 Q4	$19.5M	Hold	173,010	–	–	0.71%	29
2015 Q3	$17.5M	Hold	173,010	–	–	0.63%	35
2015 Q2	$21.3M	Hold	173,010	–	–	0.77%	29
2015 Q1	$19.8M	Hold	173,010	–	–	0.78%	33
2014 Q4	$17.5M	Sell	173,010 -65,115	-27%	-$6.33M	0.82%	32
2014 Q3	$21.7M	Buy	238,125 +42,573	+22%	+$3.74M	1.02%	27
2014 Q2	$16.8M	Sell	195,552 -110,688	-36%	-$8.72M	1.54%	18
2014 Q1	$24.1M	Sell	306,240 -102,078	-25%	-$8.51M	2.41%	14
2013 Q4	$30.9M	Buy	408,318 +156,498	+62%	+$11.1M	3.24%	10
2013 Q3	$17.6M	Buy	+251,820	New	+$16.5M	1.96%	13

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Tekla Capital Management's IBB Position: Q2 2023 in Review

Tekla Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2023 at 24,569 shares worth $3.12M. The position accounts for 0.12% of the portfolio, ranked #99.

Tekla Capital Management first reported a position in IBB in Q3 2013 and has held it in 22 quarters since. The position peaked at $30.9M in Q4 2013. 844 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

Tekla Capital Management held 24,569 shares of iShares Biotechnology ETF worth $3.12M as of Q2 2023.
Tekla Capital Management left its iShares Biotechnology ETF share count unchanged in Q2 2023.
iShares Biotechnology ETF made up 0.12% of Tekla Capital Management's portfolio in Q2 2023, its #99 holding.
Tekla Capital Management first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 22 quarters since.
Tekla Capital Management's iShares Biotechnology ETF position peaked at $30.9M in Q4 2013.
844 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.